Skip to content

Azatadine

RESPIRATORY SYSTEM

Also known as: azatadine maleate, azatidine

OfmFDA approvedATC R06AX09

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Azatadine is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1977. DrugCentral lists 2 molecular targets, including Hrh1 and HRH1. Recorded indications include Allergic conjunctivitis, Allergic rhinitis, Anaphylaxis Adjunct and Common cold.

  • Approval status: ofm (first approved 1977 by the FDA).
  • Molecular targets: Hrh1 and HRH1 (2 listed in DrugCentral).
  • Indications: Allergic conjunctivitis, Allergic rhinitis, Anaphylaxis Adjunct, Common cold and Dermatographic urticaria and others.
  • ATC code: R06AX09 (Other antihistamines for systemic use).
  • Molecular formula: C20H22N2; molecular weight 290.41 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (12)

  • Allergic conjunctivitis
  • Allergic rhinitis
  • Anaphylaxis Adjunct
  • Common cold
  • Dermatographic urticaria
  • Itching of skin
  • Nasal congestion
  • Nasal discharge
  • Seasonal allergic rhinitis
  • Sneezing
  • Urticaria
  • Vasomotor rhinitis

Contraindications (8)

  • Angle-closure glaucoma
  • Benign prostatic hyperplasia
  • Coronary arteriosclerosis
  • Diabetes mellitus
  • Hypertensive disorder
  • Hypertensive urgency
  • Hyperthyroidism
  • Retention of urine

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Histamine H1 receptorHrh1unknownKi 8.41
Histamine H1 receptorHRH1antagonist—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1977-03-29FDA——

ATC classification

ATC codeTherapeutic hierarchy
R06AX09RESPIRATORY SYSTEM › ANTIHISTAMINES FOR SYSTEMIC USE › ANTIHISTAMINES FOR SYSTEMIC USE › Other antihistamines for systemic use

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Azatadine is on its molecule page.

Molecular formulaC20H22N2
Molecular weight290.41 g/mol
CAS number3964-81-6
InChIKeySEBMTIQKRHYNIT-UHFFFAOYSA-N
PubChem CID19861
CN1CCC(CC1)=C1C2=CC=CC=C2CCC2=C1N=CC=C2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Azatadine used for?

DrugCentral lists the following indications for Azatadine: Allergic conjunctivitis, Allergic rhinitis, Anaphylaxis Adjunct, Common cold, Dermatographic urticaria, Itching of skin, Nasal congestion and Nasal discharge and others.

How does Azatadine work?

Its molecular targets in DrugCentral include Hrh1 and HRH1 (antagonist).

When was Azatadine first approved?

Azatadine was first approved by the FDA in 1977.

What is the chemical formula of Azatadine?

Azatadine has the molecular formula C20H22N2 and a molecular weight of 290.41 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1977-03-29
AgencyFDA
Targets2
Indications12
FormulaC20H22N2
DrugCentral ID268
Interactive profile